Occlutech International Ab
Clinical trials sponsored by Occlutech International Ab, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Heart implant tool safety under review in global registry Results expected Jan 2027 (estimated)
- New heart implant aims to ease heart failure burden Results expected Jun 2027 (estimated)
-
New registry tests device to seal dangerous heart valve leaks
Disease control By invitation onlyThis study follows up to 200 people who receive a special device to close leaks that can form around previously implanted heart valves. The leak can cause heart failure or destroy red blood cells. The device is placed using a thin tube through a blood vessel, avoiding open-heart …
Sponsor: Occlutech International AB • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New heart device aims to prevent strokes in patients with a hole in the heart
Disease control OngoingThis study tests a new device called the Occlutech Flex II PFO Occluder, which is used to close a small hole in the heart (PFO) that can cause strokes. The trial involves 450 people who have had a stroke with no clear cause and a PFO. Researchers want to see if the new device wor…
Sponsor: Occlutech International AB • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Heart hole device under the microscope: does it hold up?
Disease control OngoingThis study follows 50 people who have a hole in the wall between their heart's lower chambers (a perimembranous VSD). They received a special device to close the hole without open-heart surgery. Researchers are checking if the device stays in place and closes the hole properly, a…
Sponsor: Occlutech International AB • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC